Supernus proposes follow-on

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN), Rock-ville, Md. Business: Neurology, Drug delivery Date announced: 11/14/12 Type: Follow-on To be raised: Up to $86.3 million Shares: TBD Price prior: $12....